ESC 365 - Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

ESC Professional Premium Access

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Session: Risk factors and prevention: lipids (5)

Topic: Lipids

Speaker: Doctor H. Tada (Kanazawa, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

3 presentations

0 follower

8 more presentations in this session

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia

Speaker: Doctor P. Wang (Beijing, CN)

Survey on lipid management in cardiovascular primary prevention: do physicians follow the guidelines?

Speaker: Professor M. Alami (Casablanca, MA)

Remnant cholesterol predicts major cardiovascular events in cardiovascular disease patients with NAFLD

Speaker: Doctor B. Larcher (Feldkirch, AT)

Remnant cholesterol in atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Speaker: Doctor D. Delialis (Athens, GR)

Access the full session

Risk factors and prevention: lipids (5)

Speakers: Doctor H. Tada, Doctor H. Tada, Doctor P. Wang, Professor M. Alami, Doctor B. Larcher...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources